While executive management transitions bring new risks, and timing of the announcement is a bit surprising, we view the injection of new management blood favorably and believe the moves will be beneficial to Cardinal longer term.
Eric Coldwell
Our sense is that Cardinal is really focused on getting back to the basics
sense
They may not have been specific on the numbers, but it looks like the investment community is happy with it
community numbers happy investment
They need to focus on getting their clinical CRO operations to a higher level as they have increasingly relied on lab-based business,.. The key going forward is managing their growth and their infrastructure.
key growth business focus forward
This was good profitability on very good revenue growth.
growth good
If we were talking constant dollar, which is all we should be talking about, they came in at the high end of their raised guidance.
guidance end talking
This is exactly what the companies were hired to do in the first place. Drugs are not perfectly safe.
drugs safe place
If an investor pulled out of the space because of this, they don't understand what they are invested in.
space understand
management risks timing blood view
I can't get to it in time.
time
You must log in to post a comment.
There are no comments yet.